FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

 

FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

Bank of America, Lowe’s Sponsored CRT Training

Bank of America, Lowe's, and Truist Financial Corporation sponsored…
FDA Authorizes Novavax COVID Vaccine

Quad Plans Joint Naval Exercises

India, the US, Australia and Japan - members of the Washington-led…
FDA Authorizes Novavax COVID Vaccine

Taliban Proclaims Islamic Law Will Envelop the World

As the Taliban swallowed up Afghanistan, its leaders were…